A Trial Comparing Efficacy, Tolerability, and Safety of GZR101 Injection Once Daily (OD) and GZR33-70 Injection OD

Clinical trial NCT06558708 · RECRUITING

Trial details

NCT number: NCT06558708
Sponsor: Gan and Lee Pharmaceuticals, USA
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 2 Diabetes

Start date: 2024-06-28
Primary completion: 2024-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.